drugset / Trial / NCT01315470

Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF Patients

NCT01315470

Phase 1 Unknown 20 enrolled Hadassah Medical Organization
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The investigators use granulocyte colony-stimulating factor (GCSF) for the treatment of recurrent implantation failure in IVF patient with cause unknown or due to thin endometrium. Several studies showed that GCSF improves embryo development and implantation and increase pregnancy rate.

Timeline

Start
2011-06
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic 300 ug

Indications